|
| Press Releases |
|
 |
|
| Friday, August 18, 2023 |
|
|
Backed by Legend Capital, the Chinese Pet Food Industry Leader Gambol Pet Goes Public Successfully |
| On August 16, Legend Capital's portfolio company, Gambol Pet (301498.SZ), was successfully listed on the ChiNext Market of the Shenzhen Stock Exchange. Gambol Pet plans to issue 40,004,500 shares at an offering price of RMB39.99 per share, with an estimated total fundraising of approximately RMB1.6 billion. more info >> |
|
| Monday, July 31, 2023 |
|
|
Exploring New Collaborative Opportunities! The Indonesia-China Healthcare and Biotech Investment Forum Successfully Held |
| On 27 July 2023, on the eve of the highly anticipated Chengdu FISU World University Games, the Minister of Health Indonesia Budi Gunadi Sadikin accompanied Indonesian President Joko Widodo on a visit to China. more info >> |
|
| Friday, July 14, 2023 |
|
|
One More IPO of Legend Capital: Medical Device Supply Chain Service Provider GKHT Medical Goes Public Successfully |
| On July 12, Legend Capital's portfolio company, GKHT Medical Technology Co., Ltd. ("GKHT Medical"; Stock Code: 301370.SZ), was successfully listed on the ChiNext Market of the Shenzhen Stock Exchange. more info >> |
|
| Thursday, May 4, 2023 |
|
|
Empowering R&D in Special Diseases, "Next Generation" CRO Company TriApex Completes Series C with Hundreds of Millions of CNY, Led by Legend Capital |
| TriApex Laboratories Co., Ltd (hereinafter referred to as "TriApex") recently announced the completion of its Series C financing round, which was led by Legend Capital. more info >> |
|
| Friday, March 31, 2023 |
|
|
Rxilient Biotech and Junshi Biosciences form Joint Venture to develop and commercialize Toripalimab in Southeast Asia |
| On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam[1]. more info >> |
|
| Thursday, February 16, 2023 |
|
|
Led by Legend Capital, Macrolux Completes Nearly CNY100 million Series A Round |
| Shenzhen Macrolux Medical Technology Co., Ltd. (hereinafter referred to as "Macrolux") recently announced the completion of its Series A round by securing nearly CNY100 million, which is led by Legend Capital. more info >> |
|
| Wednesday, February 15, 2023 |
|
|
Innovation is the Key Benchmark, Focus on Four Healthcare Industry Sub-Sectors in 2023, Says Jafar Wang of Legend Capital |
| Legend Capital invested in 29 healthcare companies that officially disclosed financing rounds in 2022, according to the VBDATA Database. more info >> |
|
| Thursday, December 15, 2022 |
|
|
Legend Capital Portfolio Company Bespin Global Completes USD100m Series D Financing |
| Legend Capital Portfolio Company Bespin Global, a Korea-headquartered cloud services company, has recently completed its Series D round financing of USD100 million, which will be used mostly for acquisitions. more info >> |
|
| Friday, December 9, 2022 |
|
|
Led by Legend Capital, GS Biotech Completes Nearly CNY100 million Pre-A Round Financing |
| Recently, Zhongke Guosheng (Hangzhou) Technology Co., Ltd (hereinafter referred to as "GS Biotech") officially announced the completion of its nearly CNY100 million pre-A round financing, led by Legend Capital. more info >> |
|
| Sunday, November 13, 2022 |
|
|
Legend Capital Portfolio Company Atour Successfully Lists on Nasdaq |
| On the evening of November 11, Beijing time, Legend Capital portfolio company Atour Lifestyle Holdings Limited ("Atour") was officially listed on the Nasdaq Stock Exchange in the United States. It has priced its initial public offering of 4,750,000 American Depositary Shares ("ADSs") at US$11.0 per ADS. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
OBIファーマとTegMine Therapeutics、糖鎖標的ADCに関する独占的グローバルライセンス契約を締結
Jan 12, 2026 21:00: JST
|
|
|
浩鼎與 TegMine Therapeutics簽訂醣標靶ADC 全球商業授權合約
Jan 12, 2026 20:00 HKT/SGT
|
|
|
浩鼎与 TegMine Therapeutics 签订醣靶标 ADC 全球商业授权合约
Jan 12, 2026 20:00 HKT/SGT
|
|
|
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC
Jan 12, 2026 20:00 HKT/SGT
|
|
|
查理控股（OTCQB:CHUC）與IKE科技簽署協議，將推出革命性年齡驗證電子煙產品以解決FDA對青少年接觸的擔憂
Jan 12, 2026 19:00 HKT/SGT
|
|
|
查理控股公司（OTCQB:CHUC）与IKE科技签署协议，将推出革命性年龄验证电子烟产品以解决FDA对青少年获取渠道的担忧
Jan 12, 2026 19:00 HKT/SGT
|
|
|
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access
Jan 12, 2026 19:00 HKT/SGT
|
|
|
Toys & Games Fair, Baby Products Fair and Stationery & School Supplies Fair open today
Jan 12, 2026 18:26 HKT/SGT
|
|
|
Argentine Football Association (AFA) arbeitet mit Verofax zusammen, um Fans KI-gestützte Erlebnisse zu bieten
Jan 12, 2026 16:00 HKT/SGT
|
|
|
聯想之星與君聯資本所投企業精鋒醫療在港交所成功上市
Jan 12, 2026 14:43 HKT/SGT
|
|
|
联想之星与君联资本所投企业精锋医疗在港交所成功上市
Jan 12, 2026 14:43 HKT/SGT
|
|
|
Mazda Unveils MAZDA CX-6e New Battery EV in World Premiere
Jan 12, 2026 13:10 JST
|
|
|
Argentine Football Association (AFA) se asocia con Verofax para ofrecer experiencias de IA a los aficionados
Jan 12, 2026 10:00 HKT/SGT
|
|
|
Argentine Football Association (AFA), Verofax와 협력 팬을 위한 AI 경험 제공
Jan 12, 2026 10:00 HKT/SGT
|
|
|
Argentine Football Association（AFA）攜手 Verofax 為球迷提供 AI 互動體驗
Jan 12, 2026 10:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
